Cape Investment Advisory »

SPDR S&P Pharmaceuticals shares owned by Cape Investment Advisory

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Cape Investment Advisory from 13F filings

Historical chart of Cape Investment Advisory investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Cape Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Cape Investment Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 238 56.01

More positions owned by Cape Investment Advisory

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr 1 5yr Corp Bd (SCHJ)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Apple (AAPL)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)

View all positions for Cape Investment Advisory

Top funds holding SPDR S&P Pharmaceuticals

Envestnet Asset Management
LPL Financial
Wells Fargo & Company
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Susquehanna International
Bnp Paribas Arbitrage, Snc
Cetera Investment Advisers
Jpmorgan Chase & Co
UBS Group
Clark Capital Management Group
Wharton Business Group
Bp Wealth Management
Mml Investors Services
Goldman Sachs Group

View all funds holding SPDR S&P Pharmaceuticals